Universität zu Köln

2019

Leow, Jeffrey J., Bedke, Jens ORCID: 0000-0003-2778-3108, Chamie, Karim, Collins, Justin W., Daneshmand, Siamak, Grivas, Petros, Heidenreich, Axel, Messing, Edward M., Royce, Trevor J., Sankin, Alexander I., Schoenberg, Mark P., Shipley, William U., Villers, Arnauld, Efstathiou, Jason A., Bellmunt, Joaquim and Stenzl, Arnulf (2019). SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer. World J. Urol., 37 (1). S. 61 - 84. NEW YORK: SPRINGER. ISSN 1433-8726

2018

Siemens, D. Robert, Klotz, Laurence, Heidenreich, Axel, Chowdhury, Simon, Villers, Arnauld, Baron, Benoit, van Os, Steve, Hasabou, Nahla, Wang, Fong, Lin, Ping and Shore, Neal D. (2018). Efficacy and Safety of Enzalutamide vs Bicalutamide in Younger and Older Patients with Metastatic Castration Resistant Prostate Cancer in the TERRAIN Trial. J. Urol., 199 (1). S. 147 - 155. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1527-3792

2017

Heidenreich, Axel, Chowdhury, Simon, Klotz, Laurence, Siemens, David Robert, Villers, Arnauld, Ivanescu, Cristina, Holmstrom, Stefan, Baron, Benoit, Wang, Fong, Lin, Ping and Shore, Neal D. (2017). Impact of Enzalutamide Compared with Bicalutamide on Quality of Life in Men with Metastatic Castration-resistant Prostate Cancer: Additional Analyses from the TERRAIN Randomised Clinical Trial. Eur. Urol., 71 (4). S. 534 - 543. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1873-7560

2016

Chowdhury, Simon, Shore, Neal D., Villers, Arnauld, Klotz, Laurence, Siemens, D. Robert, Baron, Benoit, van Os, Steve, Hasabou, Nahla, Wang, Fong, Forer, David and Heidenreich, Axel (2016). Efficacy and safety of enzalutamide vs bicalutamide in European and North American men participating in the TERRAIN trial. J. Clin. Oncol., 34 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Siemens, D. Robert, Klotz, Laurence, Heidenreich, Axel, Chowdhury, Simon, Villers, Arnauld, Baron, Benoit, Van Os, Steve, Hasabou, Nahla, Brown, Scott, Wang, Fong, Forer, David and Shore, Neal D. (2016). EFFICACY AND SAFETY OF ENZALUTAMIDE VERSUS BICALUTAMIDE IN YOUNGER AND OLDER PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN THE TERRAIN TRIAL. Asia-Pac. J. Clin. Oncol., 12. S. 117 - 118. HOBOKEN: WILEY-BLACKWELL. ISSN 1743-7563